This inventor holds 3 USPTO granted patents. Top assignees: Cancer Research Ventures Limited, Ruprecht-Karls-Universität. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Gerhard Schilling: Innovator in Pharmaceutical Sciences
Introduction: Gerhard Schilling, an accomplished inventor based in Ladenburg, Germany, has made significant strides in the field of pharmaceutical sciences. With a total of three patents to his name, Schilling's work focuses on innovative drug formulations that have potential applications in treating various medical conditions.
Latest Patents: One of Schilling's latest inventions is a medicament containing platinum complex compounds designed for pharmaceutical preparations. This innovative formulation includes compounds of a specific general formula, which offers a variety of alkyl and alkenyl residues, including straight-chain, branched, monocyclic, and polycyclic structures. The formulation aims to be useful in immunosuppressive treatments and non-invasive medical interventions. Another notable patent involves guanidine derivatives, where Schilling has developed new chemical variants that demonstrate promising efficacy as pharmaceutical compositions.
Career Highlights: Throughout his career, Schilling has worked with esteemed organizations, contributing to the advancement of medical research. He has been associated with Cancer Research Ventures Limited, where he applied his expertise in pharmaceutical innovations. Additionally, he has collaborated with Ruprecht-Karls-Universität, engaging in cutting-edge research that bridges academia and practical applications in medicine.
Collaborations: Schilling's work is further enriched by collaborations with notable professionals, including Eberhard Amtmann and Norbert Frank. These partnerships have facilitated the exchange of ideas and fostered a research environment conducive to innovation.
Conclusion: Gerhard Schilling stands out as a dedicated inventor in the pharmaceutical field, evidenced by his impactful patents and collaborations. His innovative formulations not only enhance pharmaceutical capabilities but also open new avenues for treatment options in modern medicine. As he continues to develop groundbreaking solutions, Schilling's contributions are expected to make a lasting impact on the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile